Brief Report: A Blood-Based MicroRNA Complementary Diagnostic Predicts Immunotherapy Efficacy in Advanced-Sta ge NSCLC With High Programmed Death-Ligand 1 Express ion.
JTO Clin Res Rep
; 3(8): 100369, 2022 Aug.
Article
in En
| MEDLINE
| ID: mdl-35880086
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Diagnostic_studies
/
Guideline
/
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
JTO Clin Res Rep
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: